Notable

Volume 16 | Issue 13 | 29 | Jun. 24, 2002 Previous | Next New & Notable Selected articles from faculty member reviews | Compiled by Jeffrey M. Perkel The Faculty of 1000 is aWeb-based literature awareness tool published by BioMed Central. For more information visit www.facultyof1000.com. RIBOZYME DESIGN D.H. Burke et al., "Allosteric Hammerhead Ribozyme TRAPs," Biochemistry, 41:6588-94, May 28,

Written byJeffrey Perkel
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

RIBOZYME DESIGN
D.H. Burke et al., "Allosteric Hammerhead Ribozyme TRAPs," Biochemistry, 41:6588-94, May 28, 2002.

"Hammerhead ribozyme activity has been upregulated allosterically more than 250-fold with "activator" DNA oligonucleotides that bind not to the ribozyme core, but to an "attenuator" region appended to the ribozyme. The upregulation of single-turnover activity could be increased even further by inclusion of 'antiattenuator' sequence on the activating oligo. Several features of the work offer interesting potential for more general application: (1) The assembly order of the ribozyme, substrate, and activating oligonucleotide affects the final activity level; (2) Neither the activator nor the attenuator sequences need to interact directly with the ribozyme core nucleotides; (3) Substantial knowledge of ribozyme structure or chemistry should not be needed to apply this to other systems."

--Scott K. Silverman,
University of Illinois, US

MITOCHONDRIAL INDEPENDENCE T.J. Collins et al., "Mitochondria are morphologically and functionally heterogeneous within cells," EMBO Journal, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies